Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Clinical Trials at the Nuffield Department of Medicine

Clinical trials are central to the Nuffield Department of Medicine’s mission to improve health through research. Our investigators lead innovative studies across a wide range of diseases, from early-phase experimental medicine to large international trials that change clinical practice.

As part of the University of Oxford, we contribute significantly to one of the world’s largest academic clinical trials portfolios. At any one time, the University sponsors around 1,000 studies within the EU, including approximately 150 interventional trials from phase I to IV, alongside a further 350 studies globally, many led through the NDM's Centre for Tropical Medicine and Global Health.

Our research has global impact, informing clinical guidelines and health policy, including contributions to WHO recommendations and national treatment strategies. Supported by a strong network of clinical trial units, specialist facilities, and international partnerships, we deliver high-quality research that improves patient care worldwide.

Please note this page is a new addition to our site and more information on Clinical Trials involving the Nuffield Department of Medicine will be added over time. 

What's new

A busy paediatric waiting area in the outpatient department of Angkor Hospital for Children, Siem Reap, Cambodia © Angkor Hospital for Children.

New study improves early detection of life threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.

A person being vaccinated in their arm.

New rabies vaccine could provide protection for adults and children with a single dose

A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.